Search Within

Chrisann Kyi Kyi

  1. "Martee Hensley"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Department of Medicine (8)
  2. GDMT, Medicine (8)
  3. Gynecologic Medicine Service (8)
  4. Gynecology Disease Management Team (8)
  5. Solid Tumor Oncology Division (8)
  6. Weinberg Fellows (8)

More Groups

People
  1. Claire Friedman (8)
  2. Martee Hensley (8)
  3. Carol Aghajanian (7)
  4. Rachel Grisham (7)
  5. Roisin O'Cearbhaill (7)
  6. Vicky Makker (7)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2022 (3)
  4. 2021 (1)
  5. 2018 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Gynecologic Oncology (1)
  3. Gynecologic Oncology Reports (1)
  4. International Journal of Gynecological Cancer (1)
  5. Nature Medicine (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Elsevier B.V. (1)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Nature Publishing Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety profile of mirvetuximab in folate receptor alpha-positive ovarian cancer
    Meeting Abstract

    Johannet, P.; Foote, M.; Cohen, S.; Friedman, C.; Green, A.; Guo, R.; Hensley, M.; Konner, J.; Kyi, C.; Liu, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: A phase 2 trial with biomarker analyses
    Journal Article

    Friedman, C. F.; Manning-Geist, B. L.; Zhou, Q.; Soumerai, T.; Holland, A.; Da Cruz Paula, A.; Green, H.; Ozsoy, M. A.; Iasonos, A.; Hollmann, T.; more...
    Nature Medicine (2024)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy
    Journal Article

    Kyi, C.; Friedman, C. F.; Mueller, J. J.; Benayed, R.; Ladanyi, M.; Arcila, M.; Yang, S. R.; Hensley, M. L.; Chiang, S.
    Gynecologic Oncology Reports (2021)

    Fulltext@MSK | Save
  • The clinical utility of prospective molecular characterization in advanced cervical and vulvovaginal cancer
    Meeting Abstract

    Friedman, C. F.; Donoghue, M.; Vivek, M.; Aghajanian, C.; Abu-Rustum, N.; Cadoo, K. A.; Grisham, R. N.; Hensley, M. L.; Konner, J. A.; Kyi, C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save